{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T10:45:05Z","timestamp":1794393905619,"version":"4.9.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:00:00Z","timestamp":1776470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":46,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"DOI":"10.1186\/s12894-026-02156-8","type":"journal-article","created":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T05:05:18Z","timestamp":1776488718000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Additional predictive value of systemic inflammation indices beyond prostate specific antigen density for clinically significant prostate cancer"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7344-4508","authenticated-orcid":false,"given":"Hasan","family":"Sulhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9175-2755","authenticated-orcid":false,"given":"Bedreddin","family":"Kalyenci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,18]]},"reference":[{"issue":"5","key":"2156_CR1","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3322\/caac.21731","volume":"72","author":"KD Miller","year":"2022","unstructured":"Miller KD, Nogueira L, Devasia T, Mariotto AB, Yabroff KR, Jemal A, Kramer J, Siegel RL. Cancer treatment and survivorship statistics, 2022. Cancer J Clin. 2022;72(5):409\u201336.","journal-title":"Cancer J Clin"},{"issue":"1","key":"2156_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ucl.2025.09.001","volume":"53","author":"O Nativ","year":"2026","unstructured":"Nativ O, Reid G, Sadiq S, Cuvet M, Punnen S. Prostate Cancer Screening: Evolution, Challenges, and Future Directions. Urologic Clin North Am. 2026;53(1):1\u201313.","journal-title":"Urologic Clin North Am"},{"key":"2156_CR3","doi-asserted-by":"crossref","unstructured":"Lim JH, Lo CY, Sultana R, Tay JYJ, Tiwari RV, Chan TKN, Chua Lee Kiang M, Kanesvaran R, Kok Shi Xian S, Tan MO et al. Primary MRI versus PSA-gated scans in Prostate Cancer Screening - how ready is it for mainstream implementation? Prostate cancer and prostatic diseases 2025.","DOI":"10.1038\/s41391-025-01048-6"},{"key":"2156_CR4","doi-asserted-by":"publisher","first-page":"1602134","DOI":"10.3389\/fonc.2025.1602134","volume":"15","author":"A Kadeer","year":"2025","unstructured":"Kadeer A, Maolake A, Aimaier A, Abuduwaili M, Ni Z, Li J. Diagnostic accuracy of PSA derivatives for prostate cancer in patients with low prostate-specific antigen levels. Front Oncol. 2025;15:1602134.","journal-title":"Front Oncol"},{"key":"2156_CR5","doi-asserted-by":"publisher","unstructured":"MajewskaZ, Zajkowska M, P\u0105czek S, Nowi\u0144ski AR, Sok\u00f3lska W, Gryko M, Orywal K. The Clinical Relevance of Tumor Biomarkers in Prostate Cancer-A Review. Cancers. 2025;17(23):3742 https:\/\/doi.org\/10.3390\/cancers17233742.","DOI":"10.3390\/cancers17233742"},{"key":"2156_CR6","doi-asserted-by":"publisher","first-page":"1697617","DOI":"10.3389\/fendo.2025.1697617","volume":"16","author":"G Huang","year":"2025","unstructured":"Huang G, Xiao K, Lin S, Lu X. Association of systemic inflammatory biomarkers with prostate cancer risk: a population-based (NHANES) and clinical validation study. Front Endocrinol. 2025;16:1697617.","journal-title":"Front Endocrinol"},{"key":"2156_CR7","doi-asserted-by":"publisher","first-page":"1259929","DOI":"10.3389\/fnut.2023.1259929","volume":"10","author":"Y Hai-Jing","year":"2023","unstructured":"Hai-Jing Y, Shan R, Jie-Qiong X. Prognostic significance of the pretreatment pan-immune-inflammation value in cancer patients: an updated meta-analysis of 30 studies. Front Nutr. 2023;10:1259929.","journal-title":"Front Nutr"},{"key":"2156_CR8","doi-asserted-by":"publisher","first-page":"1537542","DOI":"10.3389\/fonc.2025.1537542","volume":"15","author":"CL Liang","year":"2025","unstructured":"Liang CL, Li WD, Wang J. Preoperative immune-inflammation index in predicting the diagnosis and adverse pathological features of prostate cancer. Front Oncol. 2025;15:1537542.","journal-title":"Front Oncol"},{"issue":"1","key":"2156_CR9","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s12894-025-01882-9","volume":"25","author":"J Sun","year":"2025","unstructured":"Sun J, Song Y, Tan Y, Ma L, Xie H. Predictive value of inflammatory marker PLR in prostate cancer. BMC Urol. 2025;25(1):188.","journal-title":"BMC Urol"},{"key":"2156_CR10","doi-asserted-by":"publisher","first-page":"1326083","DOI":"10.3389\/fimmu.2024.1326083","volume":"15","author":"T Kuang","year":"2024","unstructured":"Kuang T, Qiu Z, Wang K, Zhang L, Dong K, Wang W. Pan-immune inflammation value as a prognostic biomarker for cancer patients treated with immune checkpoint inhibitors. Front Immunol. 2024;15:1326083.","journal-title":"Front Immunol"},{"issue":"13","key":"2156_CR11","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1002\/pros.24762","volume":"84","author":"R Kayar","year":"2024","unstructured":"Kayar R, Tokuc E, Ozsoy E, Demir S, Kayar K, Topaktas R, Demir S, Ozturk M. The predictive impact of hematological inflammatory markers in detecting prostate cancer in patients with PI-RADS 3 lesions on multiparametric magnetic resonance imaging. Prostate. 2024;84(13):1244\u201350.","journal-title":"Prostate"},{"issue":"1","key":"2156_CR12","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s12894-024-01617-2","volume":"24","author":"J Dahan","year":"2024","unstructured":"Dahan J, Pinthus J, Delouya G, Taussky D, Duceppe E, de Jesus A, Leong D. Investigation of association between clinically significant prostate cancer, obesity and platelet to-lymphocyte ratio and neutrophil -to-lymphocyte ratio. BMC Urol. 2024;24(1):226.","journal-title":"BMC Urol"},{"key":"2156_CR13","doi-asserted-by":"crossref","unstructured":"Kacan T, Demir DO, Yildiz AK, Gokkurt Y, Erbay OF, Yazar VM, Keseroglu BB, Karakan T. Can the systemic immune-inflammation index be used to differentiate benign and malignant pathologies before transrectal ultrasound-guided prostate biopsy? BMC urology 2025.","DOI":"10.1186\/s12894-025-02011-2"},{"issue":"1","key":"2156_CR14","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/pros.24804","volume":"85","author":"SC Yazgan","year":"2025","unstructured":"Yazgan SC, Yekeduz E, Araz M, Bolek H, Kucuk NO, Urun Y. The prognostic role of pan-immune inflammation value in patients with metastatic castration resistance prostate cancer treated with Lutetium-177 ((177)Lu)-PSMA-617. Prostate. 2025;85(1):90\u20136.","journal-title":"Prostate"},{"issue":"11","key":"2156_CR15","doi-asserted-by":"publisher","first-page":"3306","DOI":"10.12669\/pjms.41.11.12852","volume":"41","author":"F Jiang","year":"2025","unstructured":"Jiang F, Zhou P. Prognostic significance of systemic immune inflammation index and systemic inflammation response index for cervical cancer: A systematic review and meta-analysis. Pakistan J Med Sci. 2025;41(11):3306\u201315.","journal-title":"Pakistan J Med Sci"},{"issue":"4","key":"2156_CR16","doi-asserted-by":"publisher","first-page":"368504251408872","DOI":"10.1177\/00368504251408872","volume":"108","author":"PY Lin","year":"2025","unstructured":"Lin PY, Lin YH, Wen MH, Cheng PC, Wu PH, Lo WC, Chang CM, Liao LJ. Prognostic significance of the neutrophil-to-lymphocyte ratio (NLR), systemic immune-inflammation index (SII), systemic inflammation response index (SIRI) and panimmune-inflammation value (PIV) in head and neck squamous cell carcinoma (HNSCC): A retrospective cohort study. Sci Prog. 2025;108(4):368504251408872.","journal-title":"Sci Prog"},{"key":"2156_CR17","doi-asserted-by":"publisher","first-page":"102627","DOI":"10.1016\/j.tranon.2025.102627","volume":"64","author":"Z Huang","year":"2025","unstructured":"Huang Z, Luo J, He J, Hu Q, Liao R, Xu J, Guo P, Liu Z, You N, Zhou B, et al. Comparative prognostic value of preoperative SII, NLR, and MLR and their association with TNM staging in gallbladder cancer: A multicenter retrospective study. Translational Oncol. 2025;64:102627.","journal-title":"Translational Oncol"},{"issue":"1","key":"2156_CR18","doi-asserted-by":"publisher","first-page":"2601171","DOI":"10.1080\/01443615.2025.2601171","volume":"45","author":"Q Zhan","year":"2025","unstructured":"Zhan Q, Xu N, Fan J, Wang J, Li F. Prognostic value of systemic immune-inflammation index in cervical cancer: a systematic review and meta-analysis. J Obstet gynaecology: J Inst Obstet Gynecol. 2025;45(1):2601171.","journal-title":"J Obstet gynaecology: J Inst Obstet Gynecol"},{"issue":"16","key":"2156_CR19","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1002\/pros.24222","volume":"81","author":"MC Cho","year":"2021","unstructured":"Cho MC, Yoo S, Choo MS, Son H, Jeong H. Lymphocyte-to-monocyte ratio is a predictor of clinically significant prostate cancer at prostate biopsy. Prostate. 2021;81(16):1278\u201386.","journal-title":"Prostate"},{"issue":"2","key":"2156_CR20","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/s41391-020-0209-3","volume":"23","author":"Y Guan","year":"2020","unstructured":"Guan Y, Xiong H, Feng Y, Liao G, Tong T, Pang J. Revealing the prognostic landscape of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in metastatic castration-resistant prostate cancer patients treated with abiraterone or enzalutamide: a meta-analysis. Prostate Cancer Prostatic Dis. 2020;23(2):220\u201331.","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"9","key":"2156_CR21","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1089\/end.2020.0283","volume":"34","author":"M Antonucci","year":"2020","unstructured":"Antonucci M, Defidio L, De Dominicis M, Russo N, Nacchia A, Lombardo R, Patel A. Utility of Preoperative Neutrophil\/Lymphocyte Ratio as a New Objective Prognostic Tool in Endoscopically Treated Upper Tract Urothelial Carcinoma: A Retrospective Evaluation. J Endourol. 2020;34(9):993\u20131000.","journal-title":"J Endourol"},{"issue":"4","key":"2156_CR22","first-page":"187","volume":"22","author":"HA Ates","year":"2025","unstructured":"Ates HA, Aktas S, Araci MHE, Okucu E, Yalcin B, Koseoglu H. Predictive Value of Systemic Inflammatory Markers in the Prognosis of Prostate Cancer with Variant Histology. Urol J. 2025;22(4):187\u201392.","journal-title":"Urol J"},{"key":"2156_CR23","doi-asserted-by":"publisher","first-page":"820","DOI":"10.3390\/jcm12030820","volume":"12","author":"M Zhu","year":"2023","unstructured":"Zhu M, Zhou Y, Liu Z, Jiang Z, Qi W, Chen S, Wang W, Shi B, Zhu Y. Diagnostic Efficiency of Pan-Immune-Inflammation Value to Predict Prostate Cancer in Patients with Prostate-Specific Antigen between 4 and 20 ng\/mL. J Clin Med vol. 2023;12:820.","journal-title":"J Clin Med vol"},{"key":"2156_CR24","doi-asserted-by":"publisher","first-page":"111388","DOI":"10.1016\/j.compbiomed.2025.111388","volume":"201","author":"F Mirala","year":"2025","unstructured":"Mirala F, Soltani M. Patient-derived geometry-integrated multiphysics framework: Computational optimization of immunotherapeutic nanoparticle delivery via tumor microenvironment reprogramming in prostate cancer. Comput Biol Med. 2025;201:111388.","journal-title":"Comput Biol Med"},{"issue":"5","key":"2156_CR25","first-page":"631","volume":"73","author":"DEN C","year":"2021","unstructured":"C DEN, Giglio S, Baldassarri V, Cirombella R, Mallel G, Nacchia A, Tubaro A, Vecchione A. Impairment of autophagy may represent the molecular mechanism behind the relationship between obesity and inflammation in patients with BPH and LUTS. Minerva Urol Nephrol. 2021;73(5):631\u20137.","journal-title":"Minerva Urol Nephrol"},{"issue":"1","key":"2156_CR26","doi-asserted-by":"publisher","first-page":"14801","DOI":"10.1038\/s41598-023-41781-3","volume":"13","author":"R Ahmed","year":"2023","unstructured":"Ahmed R, Hamdy O, Awad RM. Diagnostic efficacy of systemic immune-inflammation biomarkers in benign prostatic hyperplasia using receiver operating characteristic and artificial neural network. Sci Rep. 2023;13(1):14801.","journal-title":"Sci Rep"},{"issue":"1","key":"2156_CR27","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41391-017-0024-7","volume":"21","author":"T Nordstr\u00f6m","year":"2018","unstructured":"Nordstr\u00f6m T, Akre O, Aly M, Gr\u00f6nberg H, Eklund M. Prostate-specific antigen (PSA) density in the diagnostic algorithm of prostate cancer. Prostate Cancer Prostatic Dis. 2018;21(1):57\u201363.","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"3","key":"2156_CR28","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.euf.2019.06.014","volume":"6","author":"M Maggi","year":"2020","unstructured":"Maggi M, Panebianco V, Mosca A, Salciccia S, Gentilucci A, Di Pierro G, Busetto GM, Barchetti G, Campa R, Sperduti I, et al. Prostate Imaging Reporting and Data System 3 Category Cases at Multiparametric Magnetic Resonance for Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol focus. 2020;6(3):463\u201378.","journal-title":"Eur Urol focus"},{"issue":"1","key":"2156_CR29","doi-asserted-by":"publisher","first-page":"20015","DOI":"10.1038\/s41598-020-76786-9","volume":"10","author":"I Yusim","year":"2020","unstructured":"Yusim I, Krenawi M, Mazor E, Novack V, Mabjeesh NJ. The use of prostate specific antigen density to predict clinically significant prostate cancer. Sci Rep. 2020;10(1):20015.","journal-title":"Sci Rep"},{"issue":"1","key":"2156_CR30","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41391-024-00789-0","volume":"28","author":"R Lombardo","year":"2025","unstructured":"Lombardo R, Gallo G, Stira J, Turchi B, Santoro G, Riolo S, Romagnoli M, Cicione A, Tema G, Pastore A, et al. Quality of information and appropriateness of Open AI outputs for prostate cancer. Prostate Cancer Prostatic Dis. 2025;28(1):229\u201331.","journal-title":"Prostate Cancer Prostatic Dis"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12894-026-02156-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-026-02156-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-026-02156-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:29:04Z","timestamp":1780446544000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12894-026-02156-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,18]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2156"],"URL":"https:\/\/doi.org\/10.1186\/s12894-026-02156-8","relation":{},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,18]]},"assertion":[{"value":"12 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study received approval from the Non-Interventional Clinical Research Ethics Committee of Ad\u0131yaman University (decision date: January 17, 2024, meeting number: 10, decision number: 2024\/10). Written informed consent for transrectal ultrasound (TRUS)-guided prostate biopsy was obtained as part of routine clinical care.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"136"}}